Catherine Gaudin

1.1k total citations
32 papers, 941 citations indexed

About

Catherine Gaudin is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Catherine Gaudin has authored 32 papers receiving a total of 941 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 16 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Catherine Gaudin's work include Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (7 papers) and CAR-T cell therapy research (6 papers). Catherine Gaudin is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (7 papers) and CAR-T cell therapy research (6 papers). Catherine Gaudin collaborates with scholars based in France, Argentina and United States. Catherine Gaudin's co-authors include Frédéric Triebel, Eric Angevin, Salem Chouaı̈b, Anne Caignard, Thierry Hercend, Bernard Escudier, Pierre‐Yves Dietrich, Véronique Scott, F Triebel and Christophe Ronsin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Catherine Gaudin

31 papers receiving 922 citations

Peers

Catherine Gaudin
Ee Lyn Lim United Kingdom
Oliver Dorigo United States
Renato G.S. Chirivi Italy
Nicole M. McLaughlin Australia
Rosa Conforti France
Tyler Alban United States
Kimberley Stannard Australia
Evelina Martinenaite Denmark
Elisabeth Oelmann Germany
Kiek Verrijp Netherlands
Ee Lyn Lim United Kingdom
Catherine Gaudin
Citations per year, relative to Catherine Gaudin Catherine Gaudin (= 1×) peers Ee Lyn Lim

Countries citing papers authored by Catherine Gaudin

Since Specialization
Citations

This map shows the geographic impact of Catherine Gaudin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Gaudin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Gaudin more than expected).

Fields of papers citing papers by Catherine Gaudin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Gaudin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Gaudin. The network helps show where Catherine Gaudin may publish in the future.

Co-authorship network of co-authors of Catherine Gaudin

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Gaudin. A scholar is included among the top collaborators of Catherine Gaudin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Gaudin. Catherine Gaudin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomas, Emilie, Justine Lequesne, Hélène Castel, et al.. (2025). Interaction between APOE Ɛ4 status, chemotherapy and endocrine therapy on cognitive functioning among breast cancer survivors: the CANTO-Cog longitudinal study. Breast Cancer Research. 27(1). 25–25. 1 indexed citations
2.
Franzoi, Maria Alice, Antonio Di Meglio, Stefan Michiels, et al.. (2024). Patient-Reported Quality of Life 6 Years After Breast Cancer. JAMA Network Open. 7(2). e240688–e240688. 2 indexed citations
3.
Lustberg, Maryam B., Julie Havas, Martina Pagliuca, et al.. (2024). 1818MO Development and validation of a predictive model of aromatase inhibitor musculoskeletal toxicity (AIMT) among patients (pts) with early breast cancer (EBC). Annals of Oncology. 35. S1078–S1079.
4.
Martin, Nicolas, Catherine Gaudin, Frédéric Commo, et al.. (2018). Regulation of eIF4F Translation Initiation Complex by the Peptidyl Prolyl Isomerase FKBP7 in Taxane-resistant Prostate Cancer. Clinical Cancer Research. 25(2). 710–723. 15 indexed citations
5.
Nakouzi, Nader Al, Sophie Cotteret, Frédéric Commo, et al.. (2014). Targeting CDC25C, PLK1 and CHEK1 to overcome Docetaxel resistance induced by loss of LZTS1 in prostate cancer. Oncotarget. 5(3). 667–678. 30 indexed citations
6.
Chauchereau, Anne, Nader Al Nakouzi, Catherine Gaudin, et al.. (2010). Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer. Experimental Cell Research. 317(3). 262–275. 21 indexed citations
7.
Nakouzi, Nader Al, Catherine Gaudin, Fanny Tabarin, et al.. (2009). Abstract #2944: Molecular determinants of Docetaxel-resistance in prostate cancer cells. Cancer Research. 69. 2944–2944. 1 indexed citations
8.
Chauchereau, Anne, Sylvestre Le Moulec, G. Fromont, et al.. (2007). Establishment of a new human prostate cancer cell line, IGR-CaP1, from a localized epithelial prostate cancer.. Cancer Research. 67. 3880–3880. 1 indexed citations
9.
Prade-Houdellier, Naïs, Cécile Demur, Emilie‐Fleur Gautier, et al.. (2007). Human telomerase is regulated by erythropoietin and transforming growth factor-β in human erythroid progenitor cells. Leukemia. 21(11). 2304–2310. 22 indexed citations
10.
Bielawska‐Pohl, Aleksandra, Claire Crola Da Silva, Anne Caignard, et al.. (2005). Human NK Cells Lyse Organ-Specific Endothelial Cells: Analysis of Adhesion and Cytotoxic Mechanisms. The Journal of Immunology. 174(9). 5573–5582. 34 indexed citations
11.
Blesson, Séverine, Jérôme Thiery, Catherine Gaudin, et al.. (2002). Analysis of the mechanisms of human cytotoxic T lymphocyte response inhibition by NO. International Immunology. 14(10). 1169–1178. 30 indexed citations
12.
13.
Gaudin, Catherine, et al.. (1999). A hsp70-2 Mutation Recognized by CTL on a Human Renal Cell Carcinoma. The Journal of Immunology. 162(3). 1730–1738. 80 indexed citations
14.
Dufour, Erick K., G. Carcelain, Catherine Gaudin, et al.. (1997). Diversity of the cytotoxic melanoma-specific immune response: some CTL clones recognize autologous fresh tumor cells and not tumor cell lines. The Journal of Immunology. 158(8). 3787–3795. 44 indexed citations
15.
16.
Dufour, Erick K., Caroline Flament, Guislaine Carcelain, et al.. (1997). Diversity of the cytotoxic melanoma-specific immune response: Some CTL recognize autologous fresh tumor cells and not tumor cell lines. Immunology Letters. 56. 214–214. 2 indexed citations
17.
Mami‐Chouaib, Fathia, Caroline Flament, Carine Asselin‐Paturel, Catherine Gaudin, & Salem Chouaı̈b. (1996). TCRAlpha/Beta and TCRGamma/Delta CD4− /CD8− HLA-DR alloreactive CTL clones do not use fas/fas ligand pathway to lyse their specific target cells. Human Immunology. 51(1). 13–22. 11 indexed citations
18.
Kumar, Anil, Françoise Farace, Catherine Gaudin, & Frédéric Triebel. (1996). Clonal T cell expansion induced by interleukin 2 therapy in blood and tumors.. Journal of Clinical Investigation. 97(5). 1219–1226. 15 indexed citations
19.
Caignard, Anne, et al.. (1996). In situ demonstration of renal-cell-carcinoma-specific T-cell clones. International Journal of Cancer. 66(4). 564–570. 41 indexed citations
20.
Farace, Françoise, Florence Orlanducci, Pierre‐Yves Dietrich, et al.. (1994). T cell repertoire in patients with B chronic lymphocytic leukemia. Evidence for multiple in vivo T cell clonal expansions.. The Journal of Immunology. 153(9). 4281–4290. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ee Lyn Lim Breakdown of academic impact, for papers by Oliver Dorigo Breakdown of academic impact, for papers by Renato G.S. Chirivi Breakdown of academic impact, for papers by Nicole M. McLaughlin Breakdown of academic impact, for papers by Rosa Conforti Breakdown of academic impact, for papers by Tyler Alban Breakdown of academic impact, for papers by Kimberley Stannard Breakdown of academic impact, for papers by Evelina Martinenaite Breakdown of academic impact, for papers by Elisabeth Oelmann Breakdown of academic impact, for papers by Kiek Verrijp
Rankless by CCL
2026